Detalhe da pesquisa
1.
Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: Rationale and design of a real-world pragmatic randomized clinical trial.
Am Heart J
; 237: 54-61, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722585
2.
High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults.
Influenza Other Respir Viruses
; 18(4): e13270, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569647
3.
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trial.
Vaccine
; 41(15): 2553-2561, 2023 04 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906404
4.
Antibody-mediated NK cell activation as a correlate of immunity against influenza infection.
Nat Commun
; 14(1): 5170, 2023 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37620306
5.
Immunological non-inferiority and safety of a quadrivalent inactivated influenza vaccine versus two trivalent inactivated influenza vaccines in China: Results from two studies.
Hum Vaccin Immunother
; 18(6): 2132798, 2022 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36328438
6.
Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial.
Hum Vaccin Immunother
; 16(6): 1380-1384, 2020 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31810418
7.
Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35â¯months: Analysis of data from a phase III trial in the Northern and Southern Hemispheres.
Vaccine
; 37(13): 1885-1888, 2019 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30745147
8.
Efficacy, immunogenicity, and safety of a quadrivalent inactivated influenza vaccine in children aged 6-35â¯months: A multi-season randomised placebo-controlled trial in the Northern and Southern Hemispheres.
Vaccine
; 37(13): 1876-1884, 2019 03 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30558818
9.
Corrigendum to "Impact of a quadrivalent inactivated influenza vaccine on influenza-associated complications and health care use in children aged 6 to 35 months: Analysis of data from a phase III trial in the northern and southern Hemispheres" [Vaccine 37(13) (2019) 1885-1888].
Vaccine
; 41(2): 621, 2023 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509639
10.
Quadrivalent inactivated influenza vaccine (VaxigripTetra™).
Expert Rev Vaccines
; 17(1): 1-11, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29157068
11.
Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.
Vaccine
; 26(35): 4579-84, 2008 Aug 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-18602729
12.
Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly.
Vaccine
; 26(1): 119-27, 2007 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-18063446
13.
The European CHMP criteria for influenza vaccine immunogenicity cannot be improved by the use of confidence intervals.
Vaccine
; 24(44-46): 6643-4, 2006 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16797109
14.
On the bias in HI titers and how to reduce it.
Vaccine
; 24(44-46): 6645-6, 2006 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16797802